Gene · 3785
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The fast-dissociating D2 antagonist antipsychotic JNJ-37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment. | Br J Pharmacol | 2025 | 40702669 | PubTator, text mining | PubMed |
| Bibliometric and visualized analysis of current advances and future directions in epilepsy: from molecular basis to therapy. | Front Neurol | 2025 | 40667464 | PubTator, text mining | PubMed |
| Molecular Dynamics in the Ventral Tegmental Area during Chronic Pain-Induced Negative Affect. | bioRxiv | 2025 | 40631219 | PubTator, text mining | PubMed |
| Kcnq (Kv7) channels exhibit frequency-dependent responses via partial inductor-like gating dynamics. | Commun Biol | 2025 | 40473867 | PubTator, text mining | PubMed |
| KCNQ2 variants in neonatal onset of self-limiting epilepsy. | Case Rep Perinat Med | 2025 | 40453196 | PubTator, text mining | PubMed |
| Impact of Genetic Testing Using Gene Panels, Exomes, and Genome Sequencing in Romanian Children with Epilepsy. | Int J Mol Sci | 2025 | 40429983 | PubTator, text mining | PubMed |
| A case of early epileptic encephalopathy caused by new mutation at W218C in KCNQ2 and review literature. | Biochem Biophys Rep | 2025 | 40342533 | PubTator, text mining | PubMed |
| Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy. | Children (Basel) | 2025 | 40310132 | PubTator, text mining | PubMed |
| Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy. | Epilepsia | 2025 | 40292751 | PubTator, text mining | PubMed |
| (+)-Borneol Enhances the Antiseizure Effects of Retigabine by both Pharmacokinetic and Pharmacodynamic Interaction. | Neurochem Res | 2025 | 40252115 | PubTator, text mining | PubMed |
| Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study. | Front Pediatr | 2025 | 40236662 | PubTator, text mining | PubMed |
| Disrupted synaptic gene expression in Fabry disease: Findings from RNA sequencing. | Neurobiol Dis | 2025 | 40233852 | PubTator, text mining | PubMed |
| Exploring potential key genes and disease mechanisms in early-onset genetic epilepsy via integrated bioinformatics analysis. | Neurobiol Dis | 2025 | 40180227 | PubTator, text mining | PubMed |
| A novel role of the antidepressant paroxetine in inhibiting neuronal Kv7/M channels to enhance neuronal excitability. | Transl Psychiatry | 2025 | 40175331 | PubTator, text mining | PubMed |
| Phosphatidylinositol 4,5-bisphosphate activation mechanism of human KCNQ5. | Proc Natl Acad Sci U S A | 2025 | 40172963 | PubTator, text mining | PubMed |
| STEAP4 facilitates growth, migration, and invasion of prostate carcinoma through upregulation of NOTCH4. | FASEB J | 2025 | 40171963 | PubTator, text mining | PubMed |
| Construction and Value Analysis of a Prognostic Assessment Model Based on Radiomics and Genetic Data for Colorectal Cancer. | Br J Hosp Med (Lond) | 2025 | 40135319 | PubTator, text mining | PubMed |
| A Novel Compound QO-83 Alleviates Acute and Chronic Epileptic Seizures in Rodents by Modulating KV7 Channel Activity. | CNS Neurosci Ther | 2025 | 40125810 | PubTator, text mining | PubMed |
| Electrophysiological Abnormalities and Pharmacological Corrections of Pathogenic Missense Variants in KCNQ3. | Neurosci Bull | 2025 | 40095209 | PubTator, text mining | PubMed |
| Genetic Epilepsies With Onset in Infancy and Toddlerhood: A Prospective Single-Center Study in India. | Pediatr Neurol | 2025 | 40088508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3785/papers?page=6